Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia.

Konishi, Tatsuya; Doki, Noriko; Takaki, Yasunobu; Igarashi, Aiko; Ohashi, Kazuteru

Konishi, Tatsuya; Doki, Noriko; Takaki, Yasunobu; Igarashi, Aiko; Ohashi, Kazuteru.

Afiliação

Konishi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan. n-doki@cick.jp.
Takaki Y; Radiology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan.
Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan.
Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome Bunkyo-ku, Tokyo, 113-8677, Japan.

Int J Hematol ; 109(1): 1-2, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30386961

Assuntos

Eritropoetina/uso terapêutico; Hematopoese Extramedular; Síndromes Mielodisplásicas/tratamento farmacológico; Humanos; Sacro

Palavras-chave

Extramedullary hematopoiesis (EMH); Myelodysplastic syndrome (MDS); Presacral extramedullary hematopoiesis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Hematopoese Extramedular / Eritropoetina Limite: Humans Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google